About Cytosorbents Corporation - Common Stock (CTSO)
Cytosorbents Corporation is a medical technology company that focuses on developing innovative therapeutic solutions for critical care and cardiovascular patients. Their flagship product, CytoSorb, is a blood purification device designed to remove cytokines and other harmful substances from the bloodstream during severe illnesses, such as sepsis or acute respiratory distress syndrome. The company is dedicated to advancing treatment options that improve patient outcomes and reduce healthcare costs through its cutting-edge technology, which aims to enhance the management of life-threatening conditions in hospital settings. Read More
PRINCETON, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that Dr. Phillip Chan, Chief Executive Officer, will present at the Life Sciences Forum hosted by VirtualInvestorConferences.com on Wednesday, June 24, 2026 and provide an overview and update on the Company. Following the presentation, Zacks Analyst Mr. Thomas Kerr will host a brief Q&A session with Dr. Chan and Mr. Peter Mariani, Chief Financial Officer.
As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Cytosorbents Q3 2025 earnings show a mixed quarter, beating EPS estimates but missing on revenue. The stock saw volatility despite a strengthened balance sheet.
As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
CytoSorbents (CTSO) reported Q2 2025 results with revenue of $9.62M, beating estimates, and a narrower EPS loss of -$0.05. Shares rose 4.32% post-earnings amid steady demand for CytoSorb.
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
